Resmed Inc. buy JPMorgan Chase & Co.
Start price
15.04.26
/
50%
€194.25
Target price
15.04.27
-
Performance (%)
-12.46%
Price
05.06.26
€170.05
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.46%. This prediction currently runs until 15.04.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 4.038% | 4.038% |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (RMD) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat